Literature DB >> 29536171

Polymegathism as a biomarker of mitochondrial disorders.

Josef Finsterer1, Sinda Zarrouk-Mahjoub2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29536171     DOI： 10.1007/s00417-018-3960-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic strategies for mitochondrial disorders.

Authors:  Josef Finsterer; Parayil Sankaran Bindu
Journal:  Pediatr Neurol       Date:  2014-11-15       Impact factor: 3.372

Review 2.  Genetic Counselling for Maternally Inherited Mitochondrial Disorders.

Authors:  Joanna Poulton; Josef Finsterer; Patrick Yu-Wai-Man
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

3.  Mitochondrial A3243G mutation results in corneal endothelial polymegathism.

Authors:  Mathieu F Bakhoum; Wei-Pu Wu; Eugenia C White; Jesse D Sengillo; Christian Sanfilippo; Marcelle M Morcos; K Bailey Freund; Henry D Perry; David Sarraf; Stephen H Tsang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-29       Impact factor: 3.117

4.  Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation.

Authors:  V Rummelt; R Folberg; V Ionasescu; H Yi; K C Moore
Journal:  Ophthalmology       Date:  1993-12       Impact factor: 12.079

5.  Corneal Endothelial Morphology in Children with Type 1 Diabetes.

Authors:  Mohamed Anbar; Hatem Ammar; Ramadan A Mahmoud
Journal:  J Diabetes Res       Date:  2016-06-26       Impact factor: 4.011

6.  Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-06       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.